Growing development of new vaccines and use of advanced technology to design new products are another driver for the market. However, lenient government regulations for approving Intravenous (IV) insulin infusion pumps and risks associated with using needles are the major restraints of this market. Furthermore, rise in the number of patients and increased disposable incomes among emerging countries are the key opportunities for this market.
Global Intravenous Access Devices Market Analysis by Product
On the basis of its types, an intravenous access devices market is segmented into Intravenous Catheters, Intravenous Infusion Pumps and Intravenous Needles. It is further subcategorized by the type of products. Intravenous catheters are one of the promising segments of Global Intravenous access devices market and it is expected to grow at healthy CAGR due to the rising incidences of diseases such as tuberculosis and cancer and the growing geriatric population worldwide.
Global Intravenous Access Devices Market Analysis by Geography
The intravenous access devices market is segmented according to geography into North America, Europe, Asia-Pacific and LAMEA. The North American region holds the dominant share in this market due to growing geriatric population and patient pool. However, the Asia-pacific region would have a high growth rate due to rise in target diseases, growing geriatric population, significant healthcare expenditure, and improving healthcare infrastructure.
The key companies profiled in this report are Becton, Dickinson & Company, B. Braun Melsungen AG, Teleflex Incorporated, Medtronic, Inc., Smiths Medical, Hospira, Inc., Covidien Plc, Fresenius Medical Care AG & Co., CareFusion Corporation and Baxter International. The key developmental strategies for these companies are improving medication management, lowering the cost of their products, lowering the risk of infection and partnering with their customers in healthcare industries.
HIGH LEVEL ANALYSIS
Analysis of the market based on Porter’s Five Force model suggests that the bargaining power of the supplier is high as the patient pool is growing and these devices are used for many treatments and for diagnosis purposes. Threat of new entrants is low as the capital investment required for this market is high. Growth in the IV access device market and rise in target diseases has increased the demand for these devices for consistent disease monitoring. This has shaped the platform for leading companies to gain more competencies in the market.
The market is segmented by type of product, which would enable a deeper understanding of the scope for this market.
Geographic segmentation would enable stakeholders to make region specific plans for growth in untapped regions.
Analysis provides an overview of the market like its drivers, opportunities and restraints. Moreover, Porter’s Five Force Model and SWOT analysis are strategically discussed for the global intravenous access devices market.
The analysis assists in understanding the strategies adopted by the companies for the growth of the intravenous access devices market.
The market is segmented into products and geographies as follows:
Midline Peripheral Catheter
Centrally Inserted Catheters
* This report will be delivered in 12 Business Days. *
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.